R&D ‘undercooked’ amid financial pressures but progress being made on industry collaboration, business leaders say by Steve Jones August 18, 2025August 18, 2025 Research and development into medicinal cannabis has fallen victim to the financial pressure companies are under, […]
News in brief: Althea completes medical cannabis asset sales; Argent begins clinical supply in Slovenia; ECS backs UWA trial for sleep apnoea by Adam Sheldon July 8, 2025July 9, 2025
Consistent supply a priority for ECS despite share price ‘frustration’ by Steve Jones April 30, 2025May 1, 2025
Retail strategy delivering close to half of ECS Botanics sales revenue, Q3 figures show by Steve Jones April 28, 2025April 29, 2025
News in brief: ECS ups NAB facility for Terphogz launch; Helius boss departs by Steve Jones and Martin Lane April 14, 2025April 16, 2025
ECS Botanics posts A$2m loss but flags record orders for second half of FY25 by Steve Jones March 2, 2025March 3, 2025
ECS Botanics sales fall amid shift to consumer strategy by Steve Jones January 29, 2025January 29, 2025
ECS hails 50% increase in yields from new protective crop enclosures by Martin Lane December 16, 2024April 11, 2025
ECS ramps up in-house range with launch of ‘value brand’ by Steve Jones and Martin Lane November 15, 2024November 21, 2024
ECS Botanics revenues rise again with retail strategy ‘growing strongly’ by Steve Jones October 23, 2024February 25, 2025
